Metabolife Liability Reversal Offers Precedent For Ephedra Defendants
This article was originally published in The Tan Sheet
Executive Summary
Defendants' prospects in future ephedra liability suits may have been strengthened by a FDL-1federal appeals court reversal of a $4.1 mil. jury award against Metabolife
You may also be interested in...
Chattem Cites “Dearth Of Good Brands” For Quiet M&A Activity
A string of settled PPA and ephedra cases will allow Chattem to focus more of its bottom line on product development and potential acquisitions
Chattem Cites “Dearth Of Good Brands” For Quiet M&A Activity
A string of settled PPA and ephedra cases will allow Chattem to focus more of its bottom line on product development and potential acquisitions
Chattem Cites “Dearth Of Good Brands” For Quiet M&A Activity
A string of settled PPA and ephedra cases will allow Chattem to focus more of its bottom line on product development and potential acquisitions